Archive — US — techcrunch
Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startupManus
Reid Hoffman is leaving Microsoft's board to focus on his AI startup, Manus, after a successful tenure. Hoffman, who joined after LinkedIn's acquisition, was involved in significant investments such as OpenAI. He aims to return to founder mode to advance Manus in drug discovery, specifically leveraging AI to innovate cancer treatments.
Key points
- Reid Hoffman steps down from Microsoft's board after ten profitable years.
- Joined Microsoft board post-LinkedIn acquisition in 2016 for $26.2 billion.
- Contributed to Microsoft's $1 billion investment in OpenAI in 2019.
- Hoffman left the OpenAI board due to conflicts of interest in 2023.
- Microsoft acquired his AI startup, Inflection AI, for $650 million.
- Hoffman is co-founder and chairman of Manus, which raised over $50 million.
- Dr. Siddhartha Mukherjee is CEO of Manus, focusing on AI for drug discovery.
- Hoffman emphasizes excitement about Manus's progress and aims to return to founder mode.
Why it matters
- Hoffman's departure signifies a trend of tech leaders shifting focus to startups.
- The rise of AI in drug discovery aligns with ongoing advancements in healthcare technology.
- Current IT trends emphasize AI's role in healthcare, especially post-pandemic.
- Investments in AI startups reflect a growing interest in leveraging technology for life sciences.
Hoffman's shift back to founder mode highlights the intersection of AI and healthcare innovation, positioning Manus to potentially lead in cancer treatment advancements amid evolving IT trends.